Compound ID |
Cluster
|
Compound Type
|
Target/Cell | Structure | Activity | Assay Description | Source | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Type
|
Relation
|
Value
|
Unit
|
||||||||
NAs.001044 | 2 | all-match | P2Y purinoceptor 1 | ![]() |
EC50 | = | 8000.0 | nM | Evaluated for agonist activity against phospholipase C coupled P2Y purinoceptor 1 (P2Y1) of turkey erythrocytes | CHEMBL1135773 | |
NAs.001044 | 2 | all-match | Unchecked | ![]() |
Other | None | 35481.3 | nM | PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) | CHEMBL1201862 | |
NAs.001044 | 2 | all-match | DNA-(apurinic or apyrimidinic site) lyase | ![]() |
Other | None | 11220.2 | nM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | CHEMBL1201862 | |
NAs.001044 | 2 | all-match | Unchecked | ![]() |
Other | None | 35481.3 | nM | PubChem BioAssay. qHTS for Inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) | CHEMBL1201862 | |
NAs.001044 | 2 | all-match | Uracil nucleotide/cysteinyl leukotriene receptor | ![]() |
Other | None | None | None | Displacement of [3H]PSB-12150 from human GPR17 expressed in CHO-K1 cell membranes up to 1 mM after 60 mins by liquid scintillation counting | CHEMBL3259593 | |
NAs.001044 | 2 | all-match | Unchecked | ![]() |
Other | None | None | % | Inhibition of Helicobacter pylori recombinant alpha1,3-fucosyltransferase using GDP-[14C]-fucose preincubated for 30 mins by liquid scintillation counting | CHEMBL3351541 | |
NAs.001044 | 2 | all-match | Fucosyltransferase 9 | ![]() |
Other | None | None | % | Inhibition of human recombinant alpha1,3-fucosyltransferase 9 using GDP-[14C]-fucose preincubated for 30 mins by liquid scintillation counting | CHEMBL3351541 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.14 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as SPQKPIVR accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.24 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as VFLPNK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Transient receptor potential cation channel subfamily M member 2 | ![]() |
Other | None | None | % | Antagonist activity at human TRPM2 expressed in HEK293 cells assessed as inhibition of ADPR-induced maximum outward potassium current at 900 uM at +15 mV by whole-cell patch-clamp electrophysiology | CHEMBL3108672 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.21 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as 7VVPAR accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.34 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as SIPIPQPFRPADEDHR accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.28 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as GDGGSTTGLSATPPASLPGSLTNVK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 0.83 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as DSSDDWEIPDGQITVGQR accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.18 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as IGSGSFGTVYK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 0.99 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as WHGDVAVK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.13 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as NEVGVLR accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 0.86 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as LIDIAR accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.22 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as QTAQGMDYLHAK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.34 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as DSLKK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 0.32 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as SIIHRDLK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Heat shock protein HSP 90-alpha | ![]() |
IC50 | = | 59308.0 | nM | Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from HSP90alpha (unknown origin) after 24 hrs by fluorescence polarization assay | CHEMBL2417440 | |
NAs.001044 | 2 | all-match | Heat shock protein 90 beta | ![]() |
IC50 | = | 11447.0 | nM | Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from dog Grp94 after 24 hrs by fluorescence polarization assay | CHEMBL2417440 | |
NAs.001044 | 2 | all-match | Regulator of G-protein signaling 4 | ![]() |
Other | None | 1191.7 | nM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | CHEMBL1201862 | |
NAs.001044 | 2 | all-match | No relevant target | ![]() |
Other | = | 4.0 | hr | Half life in Tris buffer at pH 9.8 at 0.2 mg by HPLC in presence of alkaline phosphatase | CHEMBL2177082 | |
NAs.001044 | 2 | all-match | Serum | ![]() |
Other | = | 2.0 | hr | Half life in human serum at 40 mM by HPLC | CHEMBL2177082 | |
NAs.001044 | 2 | all-match | Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | ![]() |
Other | = | 25.0 | % | Stability of the compound assessed as human eNPP1-mediated degradation of compound measuring increase in NMP level at pH 8.5 at 0.2 mM after 20 mins by HPLC relative to control | CHEMBL2177082 | |
NAs.001044 | 2 | all-match | Streptavidin | ![]() |
Other | None | None | None | Binding affinity to Streptomyces avidinii streptavidin at 4 mM using dye labeled Streptavidin binding aptamer by fluorescence spectral analysis method | CHEMBL2202973 | |
NAs.001044 | 2 | all-match | NON-PROTEIN TARGET | ![]() |
Other | None | None | % | Antioxidant activity in rat liver mitochondria assessed as inhibition of Ca2+/phosphate induced mitochondrial swelling at 50 uM by spectrophotometry | CHEMBL2321800 | |
NAs.001044 | 2 | all-match | NON-PROTEIN TARGET | ![]() |
Other | None | None | % | Antioxidant activity in rat brain mitochondria assessed as inhibition of Ca2+/phosphate induced mitochondrial swelling by spectrophotometry | CHEMBL2321800 | |
NAs.001044 | 2 | all-match | Serum | ![]() |
Other | = | 32.0 | % | Metabolic stability in human serum assessed as compound remaining at 0.1 mg after 6 hrs by HPLC analysis | CHEMBL2384903 | |
NAs.001044 | 2 | all-match | Heat shock protein HSP 90-beta | ![]() |
IC50 | = | 42159.0 | nM | Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from recombinant HSP90beta (unknown origin) after 24 hrs by fluorescence polarization assay | CHEMBL2417440 | |
NAs.001044 | 2 | all-match | PC-12 | ![]() |
IC50 | = | 21000.0 | nM | Antioxidant activity in rat PC12 cells assessed as inhibition of Fe2+-induced ROS production after 1 hr by DCFH-DA staining-based fluorometric analysis | CHEMBL2384903 | |
NAs.001044 | 2 | all-match | NON-PROTEIN TARGET | ![]() |
IC50 | = | 170000.0 | nM | Antioxidant activity assessed as inhibiton of Fe2+-induced Fenton reaction-mediated hydroxyl radical formation from H2O2 measured for 150 secs by ESR analysis in presence of DMPO | CHEMBL2384903 | |
NAs.001044 | 2 | all-match | Purinergic receptor P2Y11 | ![]() |
EC50 | = | 1700.0 | nM | Agonist activity at human GFP-tagged P2Y11R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay | CHEMBL2384903 | |
NAs.001044 | 2 | all-match | Purinergic receptor P2Y1 | ![]() |
EC50 | = | 24.0 | nM | Agonist activity at human GFP-tagged P2Y1R transfected in human 1321N1 cells assessed as induction of intracellular calcium mobilization by fluorescence assay | CHEMBL2384903 | |
NAs.001044 | 2 | all-match | Endoplasmin | ![]() |
Other | = | 2.3 | uM | Binding affinity to GRP94 (unknown origin) | CHEMBL2417440 | |
NAs.001044 | 2 | all-match | Heat shock protein HSP 90-beta | ![]() |
Other | = | 34.0 | uM | Binding affinity to HSP90beta (unknown origin) | CHEMBL2417440 | |
NAs.001044 | 2 | all-match | Heat shock protein HSP 90-alpha | ![]() |
Other | = | 51.0 | uM | Binding affinity to HSP90alpha (unknown origin) | CHEMBL2417440 | |
NAs.001044 | 2 | all-match | Heat shock protein HSP90 | ![]() |
Other | = | 41.0 | uM | Binding affinity to HSP90 (unknown origin) | CHEMBL2417440 | |
NAs.001044 | 2 | all-match | Heat shock protein 75 kDa, mitochondrial | ![]() |
IC50 | = | 55594.0 | nM | Displacement of 5-(3-(3-(6-amino-8-(6-iodobenzo[d][1,3]dioxol-5-ylthio)-9H-purin-9-yl)propyl)thioureido)-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid from recombinant human Trap-1 after 24 hrs by fluorescence polarization assay | CHEMBL2417440 | |
NAs.001044 | 2 | all-match | NON-PROTEIN TARGET | ![]() |
IC50 | = | 30000.0 | nM | Antioxidant activity assessed as free radical scavenging activity after 7 mins by ABTS radical cation decolorization assay | CHEMBL2384903 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.9 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as SNNIFLHEDLTVK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.3 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as IGDFGLATVK accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Serine/threonine-protein kinase B-raf | ![]() |
Other | = | 1.36 | None | Binding affinity to recombinant human full-length wild type B-Raf (unknown origin) assessed as DQIIFMVGR accessible protease cleavage peptide level by LC-MS/MS analysis relative to control | CHEMBL3414549 | |
NAs.001044 | 2 | all-match | Unchecked | ![]() |
IC50 | = | 2400.0 | nM | Inhibition of BODIPY-FL-ATPgammaS binding to Thermotoga maritima His-tagged HK853 expressed in Escherichia coli BL21(DE3)pLysS Rosetta after 25 mins by fluorescence polarization assay | CHEMBL4017529 | |
NAs.001044 | 2 | all-match | Unchecked | ![]() |
Other | <= | 2.0 | degrees C | Binding affinity to Thermotoga maritima His-tagged HK853 D411A mutant expressed in Escherichia coli BL21(DE3)pLysS Rosetta assessed as change in melting temperature at 1 mM by SYPRO orange dye based differential scanning fluorimetric analysis | CHEMBL4017529 | |
NAs.001044 | 2 | all-match | Unchecked | ![]() |
Other | = | 10.0 | degrees C | Binding affinity to wild type Thermotoga maritima His-tagged HK853 expressed in Escherichia coli BL21(DE3)pLysS Rosetta assessed as change in melting temperature at 1 mM by SYPRO orange dye based differential scanning fluorimetric analysis | CHEMBL4017529 | |
NAs.001044 | 2 | all-match | HSP90 | ![]() |
Other | None | None | None | Binding affinity to Plasmodium falciparum HSP90 nucleotide binding domain at 0.5 mM by SYPRO orange dye based DSF analysis | CHEMBL4152256 | |
NAs.001044 | 2 | all-match | Unchecked | ![]() |
Other | None | None | None | Binding affinity to Plasmodium falciparum GRP94 nucleotide binding domain at 0.5 mM by SYPRO orange dye based DSF analysis | CHEMBL4152256 |